Nous sommes très heureux de vous faire part du reportage mis en place par les lauréates de la Bourse jeune reporter pour le congrès de l’ESPGHAN !
Lauréates 2024 : Sarah BAMBERGER et Mélanie AUVRAY
Elles nous ont gratifiés de deux excellents articles reprenant tous les grands thèmes et sujets abordés lors du 56ᵉ congrès de l’ESPGHAN.
Nous vous invitons à prendre connaissance de leur reportage ainsi que des articles qui ont été panachés.
SOMMAIRE
- Integrating old and novel therapies in paediatric IBD Conférence – Marina Aloi (pediatric gastroenterogy and liver unit department of maternal and child Health Sopienza University of Rome)
- Maternal infections and use of antibiotics during pregnancy and offspring risk of inflammatory bowel disease: preliminary results from two Scandinavian birth cohorts – Tereza Lerchova (Sweden)
- Therapy of De-escalation in IBD: data analysis from CEDATA registry – Sila Cekin, Germany
- Update on the New UC Guidelines – ESPGHAN in collaboration with ECCO – Eytan Wine (Professor of Pediatrics and Physiology, University of Alberta, Edmonton, Canada)
- Fatigue in paediatric IBD; more than anaemia? – Marina Aloi (pediatric gastroenterogy and liver unit department of maternal and child Health Sopienza University of Rome)
- 2023 Update of the ESPGHAN EoE guidelines: what we have learned since 2014? – Jorge Amil Dias Centro Hospitalar Universitario Sao Joao, Porto, Portugal
- Joint ESPGHAN/NASPGHAN Guidelines on Non EoE EGIDS: opening new horizons for the diagnosis and management – Alexandra Papadopoulou, University of Athens, Greece
- Asymptomatic GI eosinophilia: does it matter? – Noam Zvit, Faculty of medicine, Schneider Children Medical Center Of Israel, Petah Tikva, Israel
- Helicobacter pylori found during upper endoscopy performed for the diagnosis of the most common paediatric gastrointestinal diseases. A multicenter paediatric European Study – Kallirroi Kotilea, Université de Bruxelles, Belgique
- H. Pylori and cancer in children – Zrinjka Misak, University of Zagred, Croatia
- Update on PCR and molecular testing – Philippe Lehours, CNR des campylobacter et des helicobacters, CHU de Bordeaux, Bordeaux, France
- Summary of the updates H. Pylori ESPGHAN/NASPGHAN Guidelines 2024 – Matjaz Homan, University of Ljubljana, Slovenia
- Childhood obesity prevention: impact of nutrition during pregnancy – Christina Campoy, School of Medicine, Granada, Spain
- Interventions targeting eating speed in children and adolescents with overweight and obesity – Julian Hmailton Shield, University of Bristol
- Nutritional aspects of bariatric surgery in childhood obesity – Hadar Moran Lev, Tel Aviv medical Center, Tel Aviv, Israel
SOMMAIRE
- Is it possible to avoid liver biopsy for the diagnosis of pediatric autoimmune hepatitis in a subgroup of patients ? – V. Delle Cave, Naples, Italie
- Prévention des complications liées à la cirrhose chez les enfants en attente d’une transplantation hépatique : efficacité d’un traitement par MIDODRINE pendant 6 mois. – A. Avalareddy, Bangalore, Inde
- No difference in liver histopathology at time of Kasai portoenterostomy in patients with biliary atresia with ou without CMV infection. – U. Liliemark, Karolinska, Suede
- Maralixibat impact on concomitant medication use for the treatment of cholestatic pruritus in Alagille syndrome. – J. Terner-Rosenthal, Univ Carolina, USA
- Long-term maintenance of response and improved liver health with Maralixibat in patients with PFIC. – R. Thompson, Londres, Angleterre
- In Alagille syndrome, Odevixibat elevates serum unconjugated primary bile acids in patients with pruritus relief. – E. Lindström, U.S.A
- ABO incompatible liver transplantation. – E. Gonzales, Kremlin Bicetre, France
- Biliary complications after liver transplantation. – E. Nicastro, Bergame, Italie
- The use of a single procedure biodegradable stenting to treat biliary anastomotic strictures in patients LT. – J. Quintero, Barcelone, Espagne
- Extrahepatic portal vein occlusion after pediatric LT. – L. Sieben, Groningen, Pays-Bas
- Identifying and managing vascular complications post-LT. – H. Van Der Doef, Groningen, Pays-Bas
- Live vaccinations post liver transplantation. – E. Rand, Chicago, U.S.A
- MASLD : the new nomenclature. – B. Koot, Amsterdam, Pays-Bas
- Recurrent acute liver failure. – D. Lenz, Heidelberg, Allemagne